Jean-Bernard Falmagne

Title: Innovations of Jean-Bernard Falmagne

Introduction

Jean-Bernard Falmagne is a notable inventor based in Wavre, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the fight against malaria. With a total of two patents to his name, Falmagne's work focuses on developing new compounds and methods to combat this deadly disease.

Latest Patents

Falmagne's latest patents include innovative compounds that are active against the tissue forms of malaria. One of his inventions relates to new quinoline derivatives containing a free amine group, which possess antimalarial properties. This includes new primaquine derivatives or their addition salts with acids. Another significant patent involves microparticles that contain an active principle against malaria, such as primaquine or its amino acid derivatives. These microparticles are designed with a biodegradable polymer that controls the release kinetics of the active principle, enhancing its effectiveness.

Career Highlights

Falmagne is associated with Ire-celltarg S.A., where he continues to advance his research and development efforts. His work has been pivotal in creating pharmaceutical compositions that utilize microcapsules for better delivery of antimalarial agents. His innovative approaches have the potential to improve treatment outcomes for malaria patients.

Collaborations

Falmagne has collaborated with notable colleagues in his field, including Philippe Pirson and Jose Bontemps. Their combined expertise contributes to the advancement of research in antimalarial therapies.

Conclusion

Jean-Bernard Falmagne's contributions to the field of pharmaceuticals, particularly in developing antimalarial compounds, highlight his innovative spirit and dedication to improving global health. His work continues to pave the way for new treatments that could save countless lives.